You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 108 No. 6, June 1990 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  EPIDEMIOLOGY AND BIOSTATISTICS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Cox Regression Analysis in Clinical Research

Daniel G. Seigel, ScD

Arch Ophthalmol. 1990;108(6):888-889.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The Cox survivorship model1 has been used widely in medical research and recently in the ophthalmic literature to analyze prognosis following alternative treatments of uveal melanoma.2-5 The purpose of this short communication is to explain what Cox regression analysis is, so that investigators will understand its role in clinical research.

The Cox model is a particular type of survivorship model. More generally, survivorship models are used to describe and interpret the rate at which deaths occur over time in some population. The clinical investigator may use these models to interpret the rate at which morbid events occur as well, such as loss of vision, progression of retinopathy, and marked increase in intraocular pressure. When investigators are interested in determining how a variety of factors affect the rate at which events occur (eg, treatment, characteristics of the disease, or of the patient), they may wish to use the Cox . . . [Full Text PDF of this Article]


Author Affiliations



From the National Eye Institute, Biometry and Epidemiology Program, National Institutes of Health, Bethesda, Md.


Footnotes



Accepted for publication February 22, 1990.

Reprint requests to National Eye Institute, Biometry and Epidemiology Program, National Institutes of Health, Bldg 31, Room 6A10, Bethesda, MD 20892 (Dr Seigel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.